Physician

Abhaya Pandit Trivedi

According to 2025 Medicare claims, Abhaya Trivedi (NPI: 1619293800) practices pulmonary disease in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is RUSH UNIVERSITY MEDICAL GROUP (NPI: 1093819542; TIN: 91-1780160) and primary practice location at 60612-3801. Trivedi is affiliated with the CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under the REACH model.

Trivedi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 504 traditional Medicare patients, billed 1,439 HCPCS/CPT codes, and received $78,103 in Medicare payments. The top billing code was G2211 (Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's). Part D data shows 1,427 prescription claims across 180 beneficiaries totaling $1,955,613 in drug costs, led by Tezspire (Tezepelumab-Ekko). DME data shows 272 claims. Open Payments data shows 3 records totaling $230. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $34,637 and ending at $78,103. Concurrently, Part D prescription costs have risen steadily, from $4,160 to $1,955,613. For DME billing, reported payments moved sharply higher in recent years, from $2,229 to $26,664.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	192	503	$34,637
2018	582	1,665	$145,040
2019	480	1,319	$87,516
2020	416	1,138	$110,570
2021	522	1,434	$117,284
2022	524	1,501	$103,036
2023	416	1,069	$70,440
2024	504	1,439	$78,103

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	19	47	$4,160
2017	20	78	$11,103
2018	36	153	$67,168
2019	42	214	$291,735
2020	56	264	$219,200
2021	105	549	$580,414
2022	133	874	$1,006,515
2023	154	1,111	$1,433,154
2024	180	1,427	$1,955,613

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	60	$720
2019	N/R	80	$1,000
2020	N/R	55	$1,592
2021	N/R	92	$3,333
2022	13	216	$6,188
2023	24	283	$19,814
2024	23	272	$22,329

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	88	121	$13
94375	Test to measure rate of airflow	195	201	$11
94726	Test to determine lung volumes using sensors	208	210	$10
94729	Test to examine how well the lungs exchange gases	207	209	$8
94060	Test to measure expiratory airflow and volume changes before and after medication administration	77	77	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tezspire	Tezepelumab-Ekko	159	4,452	$684,467
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	340	11,580	$241,490
Fasenra Pen	Benralizumab	36	1,932	$196,651
Nucala	Mepolizumab	22	784	$192,137
Dupixent Pen	Dupilumab	39	1,148	$155,015

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	12	$12,173
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	11	88	$6,173
E1392	Portable oxygen concentrator, rental	Y	N/R	80	$2,710
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	12	25	$647
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	N	N/R	12	$274

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$230	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abhaya Pandit Trivedi?

Tedicare shows public-source Medicare data for Abhaya Pandit Trivedi (NPI 1619293800), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abhaya Pandit Trivedi have ACO affiliation data?

Abhaya Pandit Trivedi is shown with ACO affiliation data for CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Abhaya Pandit Trivedi?

Abhaya Pandit Trivedi is linked to RUSH UNIVERSITY MEDICAL GROUP (billing NPI 1093819542) in the available physician profile data.

Does Abhaya Pandit Trivedi have Open Payments data?

Abhaya Pandit Trivedi has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.